Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
Tonix Pharmaceuticals will present data on TNX-801, its horsepox-based vaccine platform targeting mpox, at the World Vaccine Congress Europe in Amsterdam on October 19-21, 2026. The company will also lead a working group session on vectored vaccine platforms, joined by a researcher from KEMRI.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.